DexCom, Inc. (DXCM)
89.17
-1.89
(-2.08%)
USD |
NASDAQ |
Aug 25, 16:00
89.17
0.00 (0.00%)
After-Hours: 19:59
DexCom Cash from Operations (Quarterly) : 269.20M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 269.20M |
| March 31, 2026 | 525.60M |
| December 31, 2025 | 294.00M |
| September 30, 2025 | 659.90M |
| June 30, 2025 | 303.00M |
| March 31, 2025 | 183.80M |
| December 31, 2024 | 301.40M |
| September 30, 2024 | 199.50M |
| June 30, 2024 | 279.40M |
| March 31, 2024 | 209.20M |
| December 31, 2023 | 133.60M |
| September 30, 2023 | 269.20M |
| June 30, 2023 | 190.30M |
| March 31, 2023 | 155.40M |
| December 31, 2022 | 132.50M |
| September 30, 2022 | 293.20M |
| June 30, 2022 | 172.80M |
| March 31, 2022 | 71.00M |
| December 31, 2021 | 105.80M |
| September 30, 2021 | 247.30M |
| June 30, 2021 | 61.60M |
| March 31, 2021 | 27.80M |
| December 31, 2020 | 172.00M |
| September 30, 2020 | 147.60M |
| June 30, 2020 | 154.10M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.90M |
| December 31, 2019 | 143.70M |
| September 30, 2019 | 94.50M |
| June 30, 2019 | 64.50M |
| March 31, 2019 | 11.80M |
| December 31, 2018 | 33.70M |
| September 30, 2018 | 56.80M |
| June 30, 2018 | 41.40M |
| March 31, 2018 | -8.70M |
| December 31, 2017 | 41.20M |
| September 30, 2017 | 36.20M |
| June 30, 2017 | 14.30M |
| March 31, 2017 | 0.30M |
| December 31, 2016 | 13.30M |
| September 30, 2016 | 23.00M |
| June 30, 2016 | 20.10M |
| March 31, 2016 | -0.20M |
| December 31, 2015 | 11.30M |
| September 30, 2015 | 17.20M |
| June 30, 2015 | 16.10M |
| March 31, 2015 | 3.40M |
| December 31, 2014 | 8.40M |
| September 30, 2014 | 11.40M |
| June 30, 2014 | 6.20M |
| March 31, 2014 | -2.40M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Abbott Laboratories | 2.488B |
| Insulet Corp. | 88.50M |
| Baxter International, Inc. | 285.00M |
| Globus Medical, Inc. | 209.74M |
| Stryker Corp. | 1.261B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 329.80M |
| Cash from Financing (Quarterly) | -607.30M |
| Free Cash Flow | 1.405B |
| Free Cash Flow Per Share (Quarterly) | 0.473 |
| Free Cash Flow to Equity (Quarterly) | 170.90M |
| Free Cash Flow to Firm (Quarterly) | 186.85M |
| Free Cash Flow Yield | 3.96% |